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2. ABSTRACT 
The EABC® is a minimally invasive system able to perform arterialized capillary blood gas 
analysis from the earlobe (EL).  A prospective study to validate EABC® system in critical ill 
patients was performed. 55 ventilated patients, admitted to a polyvalent Intensive Care Unit 
(ICU), with an arterial catheter, were sequentially included. Patients with severe coagulopathy or 
anticoagulant therapy were excluded. Performance of the EABC® system was compared to 
Radiometer ABL 700® system. Demographic and clinical variables, vasoactive drug treatment, 
problems in the procedure and complications were registered. Qualitative variables were 
analysed using Chi-square test, quantitative variables were evaluated with Student's t test for 
paired variables and a multivariate analysis using logistic regression method was performed. A 
concordance analysis was performed using Pearson’s linear regression, Student’s t test for mean 
comparison, agreement evaluation using Bland-Altman method, and evaluation of the β 
coefficient from the correlation equation. Bilateral significance was established at p < 0.05. 
Arterialised blood sample from EL was obtained in 31 patients (56.4%) in an average time of 11 
minutes.  Risk factors were age > 65, diabetes, vasoactive drug therapy and noradrenaline (NA) 
doses above 0.22 μg / kg / min. Multivariate analysis showed age > 65 years was the only factor 
independently associated with failure. Concordance analysis and Bland-Altman agreement 
evaluation were insufficient for validating the new system for all gasometrical variables.  
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3. BACKGROUND 
The use of arterialized capillary blood from the earlobe (EL) to perform blood gas analysis 
was firstly introduced by Drs. Lilenthal and Rilley 1. The technique is based on the hypothesis 
blood from dilated capillaries of the EL, collected by a small incision and a capillary tube, contains 
a higher proportion of arterial blood than venous blood, being therefore a good estimator of 
arterial gas content. Several potential advantages of EL capillarized blood sampling compared to 
arterial puncture have been postulated, such as a lower risk of bleeding, minimized ischemic 
complications, less invasiveness and better patient tolerance. Nevertheless, studies have shown 
discordant results on the reliability of the technique to estimate arterial blood gases, which has 
limited its implementation in current clinical practice. Furthermore, a certain training degree is 
required to ensure appropriate anaerobic sampling and there is a low but relevant risk of needle 
stick injury by health care professionals. An especially designed prototype for arterialized capillary 
blood collection from the EL (Earlobe Artrialized Blood Collector, EABC®) has proven to be safe, 
with comparable results to arterial puncture in healthy volunteers, in various experimental 
situations such as head venous congestion, hypoxia and in microgravity 2,3. Additionally, it has 
been reported to be virtually painless, especially compared with arterial puncture, easy to use, 
had no complications and eliminate the risk of accidental puncture or direct blood contact by the 
operator. These advantages make the EABC® a useful system able to be operated safely by non-
trained caregivers and provide analytical capabilities in remote and isolated environments. A 
preliminary validation study in patients with chronic renal failure and haemodialysis showed 
adequate correlation with direct arterial sampling for blood gas measurement 4. Further testing is 
required for ensuring accuracy and applicability in a wider range of pathological situations, 
especially in the critically ill patient.  
This project aims to evaluate the ability to estimate arterial blood gases from the analysis of 
arterialized earlobe blood obtained and measured using the EABC® + i-Stat® system in critically ill 
patients, determine the possible adverse effects and its applicability in routine clinical practice as 
a part of its validation process before being implemented into the ISS health care system. 
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4. MATERIALS & METHODS 
Patients 
From November 2010 to May 2012, ventilated patients admitted to a polyvalent Intensive 
Care Unit (ICU), who had an arterial line, were sequentially included into the study. Patients with 
severe coagulopathy (Prothrombine Time > 2.5 ratio, Platelet count <10.000 units / dl) were 
excluded. 
Ethical issues 
The study protocol was accepted by local ethics committee (IRB: 2009593. Comité Ètic 
d’Investigació Clínica, Corporació Sanitària Universitària Parc Taulí. Sabadell, Spain) and 
informed consent was always obtained from the patient or next of a kind. 
Blood collection procedure 
A new prototype device, the Earlobe Artrialized Blood Collector (EABC®) developed by the 
microgravity Centre / FENG-PUCRS (Brazil) in collaboration with King's College of London 
(United Kingdom) was used for collecting samples of arterialized capillary blood from the EL. The 
EABC® system consisted of a plastic shell containing a small blade, a capillary heparinised tube 
and a sensor cartridge which could be interchangeable. The collecting device was coupled to the 
i-Stat® portable analyser (Abbot, United States of America), which received arterialized blood 
directly from a small skin cut, through a capillary tube, always under anaerobic conditions. 
Arterialisation was performed by massaging the EL for 2.5 min initially (first 20 patients) and later 
during 5 minutes (remaining 35 patients), with vasodilation cream (2% nitroglycerine cream) to 
ensure arterio-venous capillary shunting and sufficient blood congestion. Simultaneous blood 
samples were withdrawn and analysed.  EL arterialized blood was collected and analysed using 
the EABC® + i-Stat® (CG4+ cartridges) (Abbot, United States of America) and arterial blood 
samples were analysed using ABL 700® system (Radiometer, Denmark). Both the i-STAT® and 
ABL 700® were calibrated, maintained and updated periodically as indicated by the producer. 
After blood collection from the EL a gentle pressure was applied until haemostasis was achieved. 
Measures 
Demographic variables, diagnostic at ICU admission, illness severity determined by Acute 
Physiology and Chronic Health Evaluation II (APACHE II) score, general analytical variables, 
hemodynamic and respiratory variables, mechanical ventilation parameters, vasoactive therapy 
and drug dose (noradrenaline - NA, dopamine - Dp, dobutamine - Db, Nitroglycerine - NTG, 
Nitroprusiate - NTP, Levosimendan - LVD, Terlipressine - TLP, alone or in combination), 
presence of sepsis (as determined by the Surviving Sepsis Campaign 5), complications, total time 
to results, problems / difficulties during the procedure, sampling success / failure ratio and its 
cause were registered. High heart rate (HR > 130 beats per minute), low mean arterial pressure 
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(MAP < 65 mmHg), low cardiac output index (CI < 2.5 l/min/m2) measured by thermodilution or 
arterial pulse contour analysis, high lactate levels (> 22mg/dl) or vasoactive drug treatment were 
considered as markers of hemodynamic instability. pH, PO2, PCO2, HCO3, BE and lactate were 
determined in arterial and capillary samples. 
Data analysis 
Association between study variables and sampling success / failure ratio was evaluated and 
is presented as relative risk (RR) of sampling failure for the presence of a given variable. 
Confidence interval 95% (CI 95%) is provided whenever possible. Qualitative variables were 
analysed using Chi-square test whereas Student’s t test for paired variables was used in the case 
of quantitative variables. Hemodynamic instability variables were analysed individually and in 
combination using a linear by linear association test, which evaluated the additive effect of having 
two, three, four or five variables over sampling success ratio. Vasoactive, vasopressor and 
especially NA treatment effects were also studied. In order to estimate critical drug dose, a ROC 
(Receiving Operator Curve - Sampling Success / Drug Dose) was generated upon which a 
Youden test 6 was applied. Finally, using logistic regression method a multivariate analysis was 
performed to ascertain which variables were independently associated with sampling success / 
failure.  
Whenever sampling was possible, concordance analysis between the two methods consisted 
of a correlation test using Pearson’s linear regression method and its quadratic coefficient, mean 
difference comparison using Student’s t test, evaluation of β coefficient from the regression 
equation, and an agreement evaluation using the Bland-Altman method 7 . We applied this 
analysis procedure to the whole study population and for a subgroup of patients < 45 years old. 
Two tailed significance threshold was established at p < .05 and the 95% confidence interval was 
calculated whenever possible. Sample size calculation was made based upon previous reports. 
For a desired correlation coefficient of 0.85 with a minimum accepted ratio of 0.75, an alpha error 
of .05, and a statistical power above 0.8 sample size required was 79 patients. Statistical analysis 
was performed using SPSS version 19 (International Business Machines – IBM. Armonk, New 
York. United States of America) statistical software. 




A total of 55 patients were included in this study. Patients were predominantly males 
(72.7%), with mean age of 62 years old. Arterial hypertension and diabetes were most prevalent 
comorbidities (41.8% and 34.5%) and severe sepsis was the most frequent cause of ICU 
admission (38.1%). Mean APACHE II score was 18.28 (3 - 34). All patients were in mechanical 
ventilation with mean PEEP (Positive End Expiratory Pressure) of 7.13 (4 - 12) and received 
oxygen at mean FiO2 of 0.36 (0.21 - 0.66). Patients received treatment with vasoactive drugs in 
65.5% of the cases, being noradrenaline the most used drug (83.3%). Complete patient 
demographic, clinical characteristics, and additional study variables are described in tables 1 & 2.  
Blood collector performance 
EL blood samples were obtained in 31 patients (56.4%). The most prevalent cause of 
sampling failure was low blood flow (78.1%). Failure was more frequent in patients older than 65 
years (RR= 1.93, p = 0.04) and with diabetes (RR = 1.90 p = 0.03). Success rate was 100% in 
patients younger than 45 years old. There was a non-significant trend to higher failure rates in 
patients treated with vasoactive drugs (RR = 2; p = 0.06), this trend was also observed in a 
subgroup of patients treated with vasoconstrictor drugs (NA, Dp, TLP) but with weaker intensity 
(RR = 1.75; p = 0.094). NA treatment was not related with failure rate (RR = 1.66; p = 0.112) and 
dose was not different between patients with successful or failed blood collection (Mean Dif. = 
0.172; p = 0.805; CI 95% = -0.35 - 0.69). In contrast, NA doses above 0.22 μg/kg/min were 
associated with increased failure rates (RR = 2.37; p = 0.024). Additional factors thought to 
modify capillary blood flow and therefore increase failure rate were evaluated. Neither was the 
presence of sepsis (RR = 1.43; p = 0.262), nor were the presence of analytic signs of tissue 
hypoperfussion (lactate > 22mg/dl) (RR = 1.42; p = 0.382), severe alteration of MAP in either of 
its extreme values (<65 or >90 mmHg) (RR = 0.83; p = 0.573) and remaining variables 
associated with hemodynamic instability (HR > 130 beats per minute and CI < 2.5 l/min/m2). 
Linear by Linear analysis showed a trend to failure ratio increase the more variables were 
associated (Figure1) but without reaching significance (p=0.146). Severity at admission (APACHE 
II) was not different between patients with successful or failed blood collection (Mean Dif. = 4.22; 
p = 0.165; CI 95% = -2 - 10.4). Vasodilation and massage time (2.5 min. vs. 5 min.) did not affect 
sampling success rate, nor did fluid balance 3 hours before the procedure (Table 3). Finally 
multivariate analysis demonstrated age > 65 years was the only variable independently 
associated with sampling success ratio from the EL using the EABC® system in critical ill patients 
(Table4).  
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Learning curve 
Study population was divided chronologically in groups of 5 patients in order to determine 
whether there was a learning curve for the procedure or not. Success / failure percentages were 
recorded and its evolution throughout the study timeline is shown in Figure 2. Successes and 
failures stabilized after 35 sampling attempts at around 60% of success rate. In the last 5 patients 
success rate rose up to 80% unexpectedly. Density of patients older than 65 years in the group 
with the highest failure rate was higher but not significantly different form the group with the 
lowest failure rate (52.4% vs. 20%) 
Complications and bleeding time 
Serious complications did not occur during this study. There was one case of wound infection 
(2%), which evolved satisfactorily without specific treatment, and bleeding time was <10 min. in 
92.7% of cases. The average time to results was 11 min. (range 6 - 28 min.). No association was 
found between bleeding time and antiplatelet treatment (bleeding > 2 min. p = 0.374 ; bleeding > 
10 min. p = 0.452), prophylactic anticoagulation (bleeding > 2 min. p = 0.957 ; bleeding > 10 min. 
p = 0.924) or combination of both (bleeding > 2 min. p = 0.407 ; bleeding > 10 min. p = 0.462). 
Neither were any differences in platelet count (mean dif.= 26.8 pl x 103/dl, CI 95% = -58 - 111, p = 
0.529) or Prothrombine Time (mean dif. = 0.008, CI95% = -0.8 - 0.1, p = 0.792) between patients 
bleeding for > 2 min. from those who did not. 
Concordance analysis 
In the 31 cases where samples were obtained from the EL, correlation equation coeficients 
and mean difference comparisons between EABC® + i-Stat® system and ABL 700® for all study 
patients is presented in Table 4 and for patients < 45 years old in Table 5. PO2, SO2 and pH 
correlations were poor, acceptable for PCO2 and HCO3, and remarkable for BE and lactate. 
Regression equation β coefficient showed PO2, SO2, pH and PCO2 values were underestimated 
at higher values. Additionally, there were statistically significant mean differences for PO2, SO2, 
HCO3-, and lactate, representing a systematic error, which always underestimated values. 
Concordance did not improve in the subgroup of patients younger than 45 years old albeit 
outstanding sampling success rates. 
Agreement evaluation using Bland-Altman methods evidenced high variability in mean 
differences between arterial and capillary blood samples for all gasometrical variables and 
lactate. Furthermore, in all cases except for HCO3-, mean differences overcame tolerance limits at 
least in one occasion. Bland-Altman plots also revealed the EABC® + i-Stat® system always 
underestimated gasometrical variables. In PO2 and SO2 measures the magnitude of this error 
approximated 25% in both cases. Finally, mean difference dispersion pattern confirmed capillary 
PO2 measures were underestimated the higher the mean arterial - capillary PO2, however it was 
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not the case for SO2, pH and PCO2. HCO3- and BE mean differences showed a dual distribution 
being underestimated by capillary samples at lower values and overestimated at higher values 
(approximate threshold of 25 mEq/L for HCO3- and 2 mEq/L for BE). 
 
6. DISCUSSION 
This study has demonstrated the EABC® + i-Stat® system for estimating arterial gas values 
from EL arterialized capillary blood is not suitable for routine clinical use in critically ill patients. 
We found an excessive failure rate and age > 65 years old was a determinant factor. Vasoactive 
drugs, especially noradrenaline, and cumulative effect of hemodynamic instability could also be 
associated with increased failure rates. Whenever sampling was possible, concordance analysis 
and Bland-Altman agreement evaluation were insufficient for validating the new system.  
Arterialized capillary blood gas measurement has numerous potential advantages over direct 
arterial sampling, such as lower bleeding risk, smaller sample size, minimized ischemic 
complications, reduced invasiveness and better patient tolerance. This technique has been 
extensively evaluated in healthy volunteers at rest and during sub-maximal exercise 8 ,9 , in 
outpatients attending to a pulmonary function laboratory 10 and for the purpose of long-term 
oxygen therapy prescription 11, in patients with chronic obstructive and restrictive respiratory 
conditions 12 and with hypoxia from varied causes with 13 or without 14 tissue hypoperfussion 
signs. Some studies found good concordance of capillary gas measures with standard direct 
arterial sampling while others did not. To address the question whether EL capillary blood gas 
analysis was an accurate and reliable substitute for arterial gasometrical measures, applicable in 
routine clinical practice, a meta-analysis was performed 15 . The study concluded PO2 
measurement from the EL could be appropriate as a replacement for arterial PO2 unless precision 
was required. Pooled analysis of capillary PO2 measures showed improved agreement the lower 
the arterial PO2 (from < 123mmHg) with mean difference being markedly reduced when arterial 
PO2 was below 70mmHg. Other blood gasometrical variables like pH and PCO2 were in good 
agreement with arterial samples over a wide range of values. Poor arterialisation of the EL 
despite the utilisation of means for capillary bed arterialisation was hypothesised to be 
responsible, causing an increase in venous blood percentage when sampling at the EL. At low 
arterial PO2, the effect of venous blood admixture is depreciable whereas it becomes more 
evident at high arterio-venous PO2 differences. Since arterio-venous PCO2 differences are 
comparatively smaller, poor arterialization does not affect its measurement. Furthermore, 
collection protocols among studies included were varied and its quality could not be determined in 
all cases. Direct capillary sampling always implies a certain degree of room air contamination 
thus insufficient “anaerobical” blood collection could have significantly affected blood sample 
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quality and meta-analysis results. 
The new EABC® system together with an enhanced EL arterialization protocol were designed 
to overcome aforementioned problems. The EABC® permits procedure standardization, high 
reproducibility of collection and minimizes air contamination. Preliminary validation studies 
showed good correlation between arterial and EL capillary samples in physiological conditions 
simulating austere environments 2, in microgravity 3 and in a reduced group of patients with 
chronic renal insufficiency 4. In order to confirm its applicability in routine clinical practice, our 
study was proposed to test the system in a population of critically ill patients with a wider variety 
of diagnostics at admission, different hemodynamic status and treatments. We were able to find 
only one preceding study evaluating the accuracy of EL capillary blood gas analysis in an ICU 
environment 16. In this study, authors reported reliable arterial PCO2 estimation from the EL as 
well as for pH, HCO3- and BE measures. Nonetheless, arterial PO2 estimation showed the same 
limitations as previously reported. It has to be emphasised severe hemodynamic alterations, 
hypothermia or hyperthermia, chronic respiratory disease, high FiO2 or PEEP values, severe 
sepsis and multi-organ failure were exclusion criteria, representing an important limitation for its 
applicability to real critically ill patients. Conversely, our objectives were not only to validate the 
EABC® + i-Stat® system as an estimator of arterial blood gas values from EL arterialized capillary 
blood, but also evaluate its applicability in a wide spectrum of critically ill patients into a real ICU 
environment.  
Despite promising preliminary data, we were unable to validate the new system for various 
reasons. Firstly, a high sampling failure rate was observed due to low blood flow from the EL, 
representing an unexpected finding not evidenced in preliminary studies. Interestingly, age > 65 
years old was the only patient characteristic associated with such failure rate. Aging is 
responsible for vascular function impairment 17 and increased capillary rigidity. It may have limited 
vascular blood flow and blood delivery causing the observed low blood flow through EABC® 
capillary tube which eventually led to blood coagulation and sampling failure. The impact of age is 
evidenced in patient subgroup < 45 years old where success rate increased to 100%. Vasoactive 
drugs, moderate NA doses (> 0.22 μg/kg/min) and cumulative effect of haemodynamic instability 
variables had an effect on sampling success, although it was not always statistically significant. 
Vasodilation cream and EL rubbing were not able to overcome this problem. On the contrary, 
signs of frank tissue hypoxia such as elevated blood lactate and conditions known to cause 
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Insufficient training of operators could have also explained observed failure rates. However 
there were two qualified operators who received two training sessions during the study and had 
the possibility of interacting with the EABC® producer whenever required. Furthermore, two 
interim analyses were performed to identify possible reasons for sampling failures. 
Success/failure ratio stabilized after 35 sampling attempts suggesting a learning period had been 
overcome around the mid part of the study. Nevertheless, this hypothetical learning curve was 
probably disrupted by differential age distribution among study phases. Our opinion is provided 
the procedure simplicity sufficient skills and expertise were already acquired at early stages of the 
study.  
The statistical procedure used in this study for assessing concordance between the new 
system and the standard permitted a more accurate analysis of results than in previous reports. 
Not only correlation coefficients and mean differences were considered but also Bland-Altman 
plots and correlation equation β  coefficient were evaluated. PO2 was not concordant with 
standard, neither was SO2. Both variables showed poor correlation and were underestimated by 
the system up to 25%, which represents a clinically significant error. Furthermore, its mean 
differences with the standard were high and overcame tolerance limits in Bland-Altman plots. 
These results are similar to those previously reported in literature and could represent an 
insufficient capillary bed arterialisation and venous blood admixture. We also detected an 
increase in PO2 underestimation the higher the arterial PO2 (βcoefficient < 1 and specific mean 
difference scattering distribution in Bland-Altman plots) in all patients, showing the effect of higher 
arterio-venous differences when venous blood admixture occurs. In the case of PCO2 and pH, 
concordance analysis was better but mean differences were excessive and also overcame 
tolerance limits, which was a new finding from previous reports. Correlation coefficient was 
acceptable for HCO3- and good for BE and Lactate however, mean differences were again 
excessive. Interestingly, HCO3- and BE showed a bimodal distribution in Bland-Altman plots being 
underestimated at lower values and overestimated at higher values but no explanation has been 
found for this finding.  
It could be argued results presented in this study depict the inability of the EABC® for 
collecting an adequate blood sample. Three previous studies using this device had never 
encountered such sampling difficulties and correlation seemed to be acceptable, nonetheless, 
these studies included fewer patients and its statistical analysis was limited. Furthermore, study 
results point age of critically ill patients as the main factor affecting sampling success with a 
possible effect of vasoactive drugs, especially NA. We would like to emphasise, concordance 
analysis did not improve in patients < 45 years old in spite of outstanding successful sampling 
rates, which suggests results are not influenced by the collecting system but by the 
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characteristics of the population being studied and the limitations of EL arterialized capillary blood 
gas analysis technique itself.  
Limitations of this study were the unexpected high failure rates, which significantly slowed 
inclusion rate, and poor concordance of the new system with the standard, which was already 
observed in first patients and continued invariable despite sample size increases. Combination of 
these factors invalidated initial sample size calculations, which was based upon previous studies 
with a different population. 
Despite presented results the EABC® + i-Stat® system is a safe, fast and easy to use point of 
care device. These advantages warrant further investigation on its applicability in specific 
environments, and in selected populations of patients. Points to be addressed in the future are 
the ability of the EABC® + i-Stat® system to estimate gas partial pressure variations in arterial 
blood from the analysis of EL arterialised capillary blood, which could be in fact more informative 
than actual values in certain situations, and the exploration of extended analytical possibilities of 
the system by exchanging the EABC® cartridge.  
 
7. CONCLUSSIONS 
The EABC® + i-Stat® system for the estimation of arterial blood gases is fast and secure. An 
age > 65 years old, vasoactive drugs (especially moderate doses of NA) and hemodynamic 
instability seem to affect sampling success rates in critically ill patients. There is an insuficient 
concordance with the standard for all gasometrical variables and lactate. Concordance is not 
improved in patients < 45 years old albeit outstanding success rates. These results limit the 
applicability of this new system in routine clinical practice of critically ill patients and questions the 
validity of arterialized capillary blood samples from the EL as an estimator of arterial values. 
Other advantages, such as safety, easiness of use, quickness and portability make this system 
potentially applicable to other scenarios on selected patients. 
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9. APPENDIX 
Demographic and clinical characteristics  
Patients 55 
Male / Female 40 / 15 72.7 / 27.3% 
Age 62.75 (24 - 83) 
Comorbidities   
Arterial hypertension 23 41.8% 
Diabetes 19 34.5% 
Chronic cardiac failure 4 7.3% 
Severe vasculopathy  4 7.3% 
Renal insufficiency  5 9.1% 
Diagnostic at ICU admission   
Severe sepsis 21 38.1% 
Respiratory insufficiency 7 12.7% 
Polytrauma 7 12.7% 
Neurological 6 10.8% 
Cardiogenic shock 5 9.1% 
Other 5 9.0% 
Cardiac arrest 3 5.4% 
Haemorrhagic shock 1 1.8% 
Mechanical ventilation variables   
PEEP (cm H2O) 7.13 (4-12) 
FiO2 0.36 (0.21 - 0.66) 
Minute Volume (L/min) 9 (5.5 - 19) 
Table 1: Demographic and clinical characteristics of study patients.  
 
Study clinical variables 
 
Apache II 18.28 (3 - 34) 
Mean arterial pressure (mmHg) 80 (57-113) 
Cardiac index (l/min/m2) 3.23 (1-5.9) 
Fluid balance 3h * 0.80 (-4.8 - 4.6) 
Lactate (mg/dl) 18.75 (6-71) 
Lactate >22mg/dl 10 18% 
Sepsis 32 58.2% 
Platelets (pq x 103 / dl) 226 (54 - 669) 
Prothrombine time (ratio) 1.2 (1 - 1.9) 
Prophylactic Anticoagulant 40 72.7% 
Antiplatelet drugs 6 10.9% 
Vasoactive drugs 36 65.5% 
Noradrenaline 30 83.3% 
NA dose μg/kg/min 0.49 0.02 - 3.02 
Other Vasoconstriction drugs 3 8.2% 
Inotropic drugs 5 13.8% 
Vasodilation drugs 2 5.5% 
Table 2: Clinical variables * Fluid balance 3h before sampling (ml/Kg/h).  
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Univariate analysis 
 RR p value 
Age > 65 years 1.93 0.04 
Diabetes 1.9 0.03 
Vasoactive drugs 2 0.06 
Vasoconstrictors 1.75 0.09 
NA > .22 μg/kg/min 2.37 0.02 
Sepsis 1.43 0.26 
Lactate > 22mg/dl 1.42 0.38 
MAP (<65 or >90 mmHg) 0.83 0.57 
APACHE II 4.22* 0.16 
NA dose (μg/kg/min) 0.17* 0.80 
Table 3: Relative Risk of sampling failure for main studied 
variables. No CI 95% is available for qualitative variables 
using Chi-square test.  
*For quantitative variables APACHE II and NA dose, mean 
difference is presented. 
 
Multivariate analysis 
Variable Exp. B CI 95% p value 
Age 0.95 0.9 - 1 0.05 
Diabetes 0.42 0.1 - 1.4 0.17 
Vasoactive drugs 0.40 0.1 - 14 0.17 
Table 4: Multivariate analysis of variables which showed 
significance in univariate analysis. The variable 
Vasoactive drugs was also included for its proximity to 
signification but NA > 0.22 μg/kg/min was not since it was 
implicit in the vasoactive drugs variable.  
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Sampling success / failure and hemodynamic instability  
Figure 1: Change of sampling success / failure ratio depending on the number of 
variables of hemodynamic instability associated (HR > 130 beats x min., MAP < 65 
mmHg, CI < 2.5 l/min/m2, Lactate > 22mg/dl, vasoactive drug treatment) 
 
Evolution of success / failure ratio throughout the study 
 
Figure 2: Success / failure percentages throughout the study. Groups of 5 patients were 
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Table 4: Blood gas analysis and lactate in 31 ICU patients 
 ABL700 EABC SD R2 β  Mean dif. CI 95% p value 
pH 7.44 7.44 0.05 0.75 0.86 0.006 - 0.004 / 0.015 0.21 
PCO2 37.4 37.3 6.39 0.80 0.86 0.08 - 1 / 1.1 0.87 
PO2 80.4 69.2 8.98 0.53 0.73 11.15 8.12 / 14.2 < 0.01 
SO2 95.9 93.8 2.38 0.37 0.60 2.1 1.3 / 2.8 < 0.01 
HCO3- 26.0 25.4 4.17 0.88 0.94 0.63 0.05 / 1.2 0.03 
BE 1.6 1.2 4.59 0.91 0.95 0.39 0.1 / 0.9 0.15 
Lactate 13.3 12.2 6.47 0.95 0.97 1.1 0.6 / 1.6 < 0.01 
Concordance analysis between EABC® + i-Stat® and ABL 700® systems. 
 
Table 5: Blood gas analysis and lactate in patients < 45 years  
 ABL700 EABC SD R2 β  Mean dif. CI 95% p value 
pH 7.45 7.46 0.03 0.12 0.34 - 0.008 - 0.04 / 0.02 0.55 
PCO2 39.2 37.9 3.82 0.18 0.43 1.23 - 2.8 / 5.3 0.49 
PO2 84 72.5 13.2 0.49 0.70 11.53 3.5 / 19.5 0.01 
SO2 96.5 94.3 2.82 0.40 0.63 2.18 0.3 / 4 0.02 
HCO3- 27.5 27.3 2.32 0.73 0.85 0.25 - 1.1 / 1.6 0.68 
BE 3.4 3.6 2.50 0.80 0.89 - 0.15 - 1.5 / 1.2 0.81 
Lactate 11.8 10 3.45 0.84 0.92 1.72 0.5 / 2.8 0.01 
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Regression plots - All patients 
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